Top Medical Searches

Current Medical News

EU confronts U.S. over surveillance reports

In this picture, taken Saturday June 29, 2013, a demonstrator protests with a poster against NSA in Hanover, Germany. Germany's top justice official says reports that U.S. intelligence bugged European Union offices remind her of "the methods used by enemies during the Cold War." Justice Minister Sabine Leutheusser-Schnarrenberger was responding to a report by German news weekly Der Spiegel on Sunday June 30, 2013, that claimed the National Security Agency has eavesdropped on EU offices in Washington, New York and Brussels. The magazine cited classified U.S. documents taken by NSA leaker Edward Snowden that it said it had partly seen. The documents reportedly describe the European Union as a "target" for surveillance. (AP Photo/dpa, Peter Steffen)The European Union has demanded that the United States explain a report in a German magazine that Washington is spying on the group, using strong language to confront its closest trading partner over its alleged surveillance activities. EU High Representative Catherine Ashton said on Sunday the U.S. authorities was immediately contacted about a report in Der Spiegel magazine that the U.S. spy agency had tapped EU offices in Washington, Brussels and at the United Nations. …

Read More..

June 30th, 2013

Onyx explores possible sale after rejecting Amgen offer

By Ryan Vlastelica and Olivia Oran NEW YORK (Reuters) – Cancer drugmaker Onyx Pharmaceuticals Inc said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen Inc as too low but still is considering selling itself. Onyx said Amgen’s cash offer of $120 a share, which represents a premium of about 38 percent to the company’s Friday closing price, “significantly undervalued” its prospects. Deutsche Bank analyst Robin Karnauskas estimated Onyx’s value to a merger partner at up to $148 a share. … Read More..

June 30th, 2013

Your Choice In Utensils Can Change How Food Tastes

Cutlery, dishes and other inedible accoutrements to a meal can alter our perceptions of taste, according to researchers. And it might be more about our brains than our tongues. Read more…

June 30th, 2013

Release of Eliquis blood clot preventer story

(Reuters) The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused far less bleeding, according to data from a large clinical trial.

 Read more…

June 30th, 2013

Obamacare 1.0: States brace for Web barrage when reform goes live

NEW YORK (Reuters) – About 550,000 people in Oregon do not have health insurance, and Aaron Karjala is confident the state’s new online insurance exchange will be able to accommodate them when enrollment under President Barack Obama’s healthcare reform begins on October 1.

 Read more…

June 30th, 2013
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us